Smith Salley Wealth Management Cuts Stake in Merck & Co., Inc. (NYSE:MRK)

Smith Salley Wealth Management Cuts Stake in Merck & Co., Inc. (NYSE:MRK)

Smith Salley Wealth Management cut its holdings in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 9.1% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 152,953 shares of the company’s stock after selling 15,227 shares during the […]

Merck & Co., Inc. (NYSE:MRK) Shares Bought by RKL Wealth Management LLC

RKL Wealth Management LLC grew its position in Merck & Co., Inc. (NYSE:MRK – Free Report) by 28.3% in the first quarter, HoldingsChannel reports. The institutional investor owned 13,291 shares of the company’s stock after acquiring an additional 2,930 shares during the period. RKL Wealth Management LLC’s holdings in Merck & Co., Inc. were worth […]

RKL Wealth Management LLC Grows Holdings in Merck & Co., Inc. (NYSE:MRK)

RKL Wealth Management LLC grew its position in Merck & Co., Inc. (NYSE:MRK – Free Report) by 28.3% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 13,291 shares of the company’s stock after acquiring an additional 2,930 shares during the period. RKL Wealth Management […]

AI-Powered Stock Forecasting Algorithm | I Know First |MRK Stock Forecast: Science-Driven Growth with Blockbuster Potential

This MRK Stock Forecast article was written by Milana Ledova – Financial Analyst at I Know First Highlights Merck is doubling down on its core strengths: oncology, vaccines, and animal health. Key pipeline assets and blockbuster Keytruda will fuel near-term and long-term earnings. Valuation remains compelling versus other Big Pharma names, particularly given Merck’s innovation pipeline. Read The Full Premium Article Subscribe to receive exclusi…